Showing results (631-640 of 682) with videos related to
Sort By:
Pageof 69
Bone Marrow Transplantation|July 23, 1998
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphomaR J Soiffer, A S Freedman, D Neuberg, et al.British Journal of Haematology|June 6, 2003
Viral antigen-specific CD8+ T-cell responses are impaired in multiple myelomaBritta Maecker, Karen S Anderson, Michael S von Bergwelt-Baildon, et al.Nature Medicine|March 16, 2010
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activityDouglas W McMillin, Jake Delmore, Ellen Weisberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantationEdwin P Alyea, Edie Weller, David C Fisher, et al.Cancer Research|September 5, 2002
The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironmentBoris Lin, Klaus Podar, Deepak Gupta, et al.British Journal of Haematology|June 3, 2015
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinationsCindy Varga, Wanling Xie, Jacob Laubach, et al.Neurosurgery|May 5, 2020
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor BurdenKunal S Patel, Richard G Everson, Jingwen Yao, et al.Blood|March 9, 1999
Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myelomaR Vescio, G Schiller, A K Stewart, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemiaS P Treon, T B Agus, B Link, et al.Pageof 69